#USA #AI Technology #Cleveland #MedaSync #OHI

MedaSync Secures Strategic Investment from Omega Healthcare Investors, Inc.

CLEVELAND, Aug. 27, 2025 – In a landmark development for the healthcare technology sector, MedaSync, a prominent provider of AI-driven reimbursement optimization software, has secured a strategic investment from Omega Healthcare Investors, Inc. (NYSE: OHI). This investment marks a significant step forward in MedaSync’s mission to enhance healthcare efficiency through technology.

About MedaSync

MedaSync specializes in developing AI-powered solutions designed specifically for skilled nursing facilities. Their software streamlines reimbursement processes, ensuring that healthcare providers can efficiently manage their revenue streams amidst complex regulatory landscapes. Over the past year, the company has seen an impressive customer acquisition growth of more than 100%, underscoring the increasing demand for their innovative solutions in the healthcare sector.

Omega Healthcare's Role

Omega Healthcare Investors, a real estate investment trust focused on the healthcare industry, aims to further support MedaSync in scaling its operations. Megan Krull, Senior Vice President of Operations at Omega, will be joining the MedaSync Board of Directors. In her remarks, she emphasized the significant value MedaSync’s technology brings to skilled nursing operators looking to navigate reimbursement inefficiencies. This collaboration is anticipated to accelerate the market penetration of MedaSync’s products and foster the development of new software-as-a-service (SaaS) offerings.

Addressing Industry Challenges

The skilled nursing sector faces continuous operational pressures, particularly regarding reimbursement processes that are impacted by shifting regulations. MedaSync’s advanced cloud-based platform employs customized AI audits that meticulously analyze clinical documentation to identify reimbursement misalignments and evolving patient needs. This tailored approach ensures that skilled nursing organizations can maintain a higher quality of care, adapting swiftly to changes in reimbursement policy.

CEO Ryan Edgerly expressed his enthusiasm about the partnership, stating, "This funding is a powerful endorsement of our vision and achievements in the healthcare industry. We are excited to partner with Omega to accelerate our growth and continue to provide skilled nursing organizations an innovative solution to thrive in today's challenging reimbursement landscape." This collaboration is poised to solidify MedaSync's position as a leader in healthcare technology, particularly in the nursing sector.

A Future-Driven Approach

MedaSync’s software leverages machine learning technologies to revolutionize how reimbursement processes are handled, offering intentional insights into potential reimbursement misalignments and quality incentive risks. By providing real-time feedback tailored to each organization’s unique reimbursement landscape, MedaSync empowers skilled nursing facilities to optimize their financial outcomes while improving care quality.

In conclusion, as healthcare continues to evolve, partnerships like that of MedaSync and Omega Healthcare are crucial in fostering innovation and efficiency in the skilled nursing sector. MedaSync’s commitment to transforming the reimbursement process through AI is likely to reshape how skilled nursing facilities approach their financial and operational challenges moving forward.

For further information about MedaSync and their services, you can visit their official website at medasync.com. The stellar reputation of Omega Healthcare Investors, which operates various healthcare facilities across the U.S. and U.K., further enhances this promising collaboration as the industry anticipates what’s next for MedaSync.